+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Antifungal Drugs Market: Analysis By Drug Class, By Therapeutic Indications, By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023)

  • ID: 4750123
  • Report
  • Region: Global
  • 244 pages
  • Azoth Analytics
UP TO OFF
until Jun 15th 2019
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Astellas Pharma
  • Bayer
  • Glaxo Smith Kline
  • Kramer Laboratories
  • Merck & Co.
  • MORE
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Antifungal Drugs Market. The report analyses the Antifungal Drugs Market By Drug Type (Azoles, Echinocandins, Polyenes, Others), By Therapeutic Indications (Candidiasis, Aspergillosis, Dermatophytosis, Others). The report analyses the Antifungal Drugs Market, By Region (North America, Europe, Asia Pacific, Rest of the World) and By Country (U.S., Canada, Germany, U.K, France, China, Japan, India) for the historical period of 2013-2017 and the forecast period of 2018-2023.

According to the research report “Global Antifungal Drugs Market: Analysis By Drug Class (Azoles, Echinocandins, Polyenes, Others), By Therapeutic Indications (Candidiasis, Aspergillosis, Dermatophytosis, Others), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023) - By Region (North America, Europe, Asia Pacific, ROW), By Country (U.S., Canada, Germany, U.K, France, China, Japan, India)”, the antifungal drugs market is projected to display a robust growth represented by a CAGR of 3.70% during 2018 – 2023.
Over the recent years, Antifungal Drugs market has been witnessing growth on account of several driving factors including growing prevalence of fungal infections such as candidiasis and aspergillosis, increasing popularity of over-the-counter drugs, and increase in availability of innovative antifungals. Moreover, increasing awareness regarding fatal antifungal diseases, growing medical spending, favorable government initiatives, public private partnership have been driving the market growth. In addition, rising geriatric population, increasing global healthcare expenditure and technological advancements in pharmaceuticals research, growing scope in developing countries with large population such as China and India is anticipated to impel the market growth of the antifungal drugs market. However, growing portfolio of antifungal generic drugs, patent expiration of innovator drugs, increasing prevalence of fungal resistance, and counterfeit drugs are expected to hinder the market performance during forecasted period.

In this research report, the market is segmented on the basis of drug class and therapeutic indications. By drug class, the azoles class antifungals are predicted to hold their dominant position in the market. By therapeutic indications, drugs use in the treatment of candidiasis are anticipated to creates their dominance in global antifungal drugs market. Amongst the regions, North America accounts for the largest regional share in the global antifungal drugs market in 2017. The largest share of North America is attributed to presence of enormous number of patient base and highly advanced medical infrastructure.

The report titled “Global Antifungal Drugs Market: Analysis By Drug Class (Azoles, Echinocandins, Polyenes, Others), By Therapeutic Indications (Candidiasis, Aspergillosis, Dermatophytosis, Others), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023) - By Region (North America, Europe, Asia Pacific, ROW), By Country (U.S., Canada, Germany, U.K, France, China, Japan, India)”, has covered and analysed the potential of antifungal drugs market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the antifungal drugs. Additionally, the report also highlights market entry strategies for various companies across the globe.

Scope of the Report

Global Antifungal Drugs Market (Actual Period: 2013-2017, Forecast Period: 2018-2023)
  • Antifungal Drugs Market– Size, Growth, Forecast
  • Analysis By Drug Type - Azole Class Antifungal Drugs, Echinocandins Class Antifungal Drugs, Polyenes Class Antifungal Drugs, Other Class Antifungal Drugs
  • Analysis By Therapeutic Indications - Aspergillus, Dermatophytosis, Candidiasis, Other Therapeutic Indications
Regional Antifungal Drugs Market – North America, Europe, Asia Pacific, Rest of the World (Actual Period: 2013-2017, Forecast Period: 2018-2023)
  • Antifungal Drugs Market– Size, Growth, Forecast
  • Analysis By Drug Type - Azole Class Antifungal Drugs, Echinocandins Class Antifungal Drugs, Polyenes Class Antifungal Drugs, Other Class Antifungal Drugs
  • Analysis By Therapeutic Indications - Aspergillus, Dermatophytosis, Candidiasis, Other Therapeutic Indications
Country Analysis – U.S., Canada, Germany, U.K, France, China, Japan, India (Actual Period: 2013-2017, Forecast Period: 2018-2023)
  • Antifungal Drugs Market– Size, Growth, Forecast
  • Analysis By Drug Type - Azole Class Antifungal Drugs, Echinocandins Class Antifungal Drugs, Polyenes Class Antifungal Drugs, Other Class Antifungal Drugs
  • Analysis By Therapeutic Indications - Aspergillus, Dermatophytosis, Candidiasis, Other Therapeutic Indications
Other Report Highlights
  • Market Dynamics – Drivers and Restraints.
  • Market Trends.
  • Porter Five Forces Analysis.
  • SWOT Analysis.
  • Company Analysis - Merck & Co., Glaxo Smith Kline, Astellas Pharma, Sanofi, Abbott Laboratories, Bayer, Kramer Laboratories, Novartis International AG, Pfizer.
Customization of the Report
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Astellas Pharma
  • Bayer
  • Glaxo Smith Kline
  • Kramer Laboratories
  • Merck & Co.
  • MORE
1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4. Antifungal Drugs Products Outlook

5. Global Antifungal Drugs Market: Growth and Forecast
5.1 By Value (2013-2017)
5.2 By Value (2018-2023)

6. Global Antifungal Drugs Market: Segmental Analysis
6.1 Global Antifungal Drugs Market Size, By Drug Class: Breakdown (%)
6.1.1 Global Antifungal Drugs Market Size, By Drug Class, 2017 (%)
6.1.2 Global Antifungal Drugs Market Size, By Drug Class, 2023 (%)
6.2 Global Azole Class Antifungal Drugs Market Size, By Value (2013-2023)
6.3 Global Echinocandins Class Antifungal Drugs Market Size, By Value (2013-2023)
6.4 Global Polyenes Antifungal Drugs Market Size, By Value (2013-2023)
6.5 Global Other Antifungal Drugs Market Size, By Value (2013-2023)
6.6 Global Antifungal Drugs: Market Attractiveness, By Drug Class
6.7 Global Antifungal Drugs Market Size, By Therapeutic Indications: Breakdown(%)
6.7.1 Global Aspergillus Antifungal Drugs Market Size, By Value (2013-2023)
6.7.2 Global Dermatophytosis Antifungal Drugs Market Size, By Value (2013-2023)
6.7.3 Global Candidiasis Antifungal Drugs Market Size, By Value (2013-2023)
6.6.2 Global Other Therapeutic Indications Antifungal Drugs Market Size, By Value (2013-2023)

7. Global Antifungal Drugs Market: Regional Analysis
7.1 Global Antifungal Drugs Market Size, By Region: Breakdown (%)
7.1.1 Global Antifungal Drugs Market Size, By Region, 2017 (%)
7.1.2 Global Antifungal Drugs Market Size, By Region, 2023 (%)

8. North America Antifungal Drugs Market: An Analysis

8.1 North America Antifungal Drugs Market: Segment Analysis
8.2 North America Antifungal Drugs Market Size, By Drug Class: Breakdown (%)
8.2.1 North America Antifungal Drugs Market Size, By Drug Class, 2017 (%)
8.2.2 North America Antifungal Drugs Market Size, By Drug Class, 2023 (%)
8.3 North America Azoles Antifungal Drugs Market Size, By Value (2013-2023)
8.4 North America Echinocandins Antifungal Drugs Market Size, By Value (2013-2023)
8.5 North America Polyenes Antifungal Drugs Market Size, By Value (2013-2023)
8.6 North America Others Antifungal Drugs Market Size, By Value (2013-2023)
8.7 North America Antifungal Drugs Market Size, By Therapeutic Indications: Breakdown(%)
8.7.1 North America Aspergillus Antifungal Drugs Size, By Value (2013-2023)
8.7.2 North America Dermatophytosis Antifungal Drugs Market Size, By Value (2013-2023)
8.7.3 North America Candidiasis Antifungal Drugs Size, By Value (2013-2023)
8.7.4 North America Other Therapeutic Indications Antifungal Drugs Market Size, By Value (2013-2023)

8.8 North America Antifungal Drugs Market: Country Analysis (U.S and Canada)
8.8.1 U.S Antifungal Drugs Market, By Value (2013-2023)
8.8.2 U.S Antifungal Drugs Market, By Drug Class, By Value (2013-2023)
8.8.3 U.S Antifungal Drugs Market, By Therapeutic Indications, By Value (2013-2023)

8.8.4 Canada Antifungal Drugs Market, By Value (2013-2023)
8.8.5 Canada Antifungal Drugs Market, By Drug Class, By Value (2013-2023)
8.8.6 Canada Antifungal Drugs Market, By Therapeutic Indications, By Value (2013-2023)

9. Europe Antifungal Drugs Market: An Analysis
9.1 Europe Antifungal Drugs Market: Segmental Analysis
9.2 Europe Antifungal Drugs Market Size, By Drug Class: Breakdown (%)
9.1.2 Europe Antifungal Drugs Market Size, By Drug Class, 2017 (%)
9.1.3 Europe Antifungal Drugs Market Size, By Drug Class, 2023 (%)
9.3 Europe Azoles Antifungal Drugs Market Size, By Value (2013-2023)
9.4 Europe Echinocandins Drugs Market Size, By Value (2013-2023)
9.5 Europe Polyenes Antifungal Drugs Market Size, By Value (2013-2023)
9.6 Europe Antifungal Drugs Market Size, By Therapeutic Indications: Breakdown(%)
9.6.1 Europe Aspergillosis Antifungal Drugs Market Size, By Value (2013-2023)
9.6.2 Europe Dermatophytosis Antifungal Drugs Market Size, By Value (2013-2023)
9.6.3 Europe Candidiasis Antifungal Drugs Market Size, By Value (2013-2023)
9.6.4 Europe Other Therapeutic Indications Antifungal Drugs Market Size, By Value (2013-2023)

9.7 Europe Antifungal Drugs Market: Country Analysis (Germany, France, Italy, U.K)
9.7.1 Germany Antifungal Drugs Market, By Value (2013-2023)
9.7.2 Germany Antifungal Drugs Market, By Drug Class, By Value (2013-2023)
9.7.3 Germany Antifungal Drugs Market, By Therapeutic Indications, By Value (2013-2023)

9.7.4 France Antifungal Drugs Market, By Value (2013-2023)
9.7.5 France Antifungal Drugs Market, By Drug Class, By Value (2013-2023)
9.7.6 France Antifungal Drugs Market, By Therapeutic Indications, By Value (2013-2023)

9.7.7 UK Antifungal Drugs Market, By Value (2013-2023)
9.7.8 UK Antifungal Drugs Market, By Drug Class, By Value (2013-2023)
9.7.9 UK Antifungal Drugs Market, By Therapeutic Indications, By Value (2013-2023)

10. APAC Antifungal Drugs Market: An Analysis
10.1 APAC Antifungal Drugs Market: Segmental Analysis
10.2 APAC Antifungal Drugs Market Size, By Drug Class: Breakdown (%)
10.2.1 APAC Antifungal Drugs Market Size, By Drug Class, 2017 (%)
10.2.2 APAC Antifungal Drugs Market Size, By Drug Class, 2023 (%)
10.3 APAC Azole Antifungal Drugs Market Size, By Value (2013-2023)
10.4 APAC Echinocandins Antifungal Drugs Market Size, By Value (2013-2023)
10.5 APAC Polyenes Antifungal Drugs Market Size, By Value (2013-2023)
10.6 APAC Other Antifungal Drugs Market Size, By Value (2013-2023)
10.7 APAC Antifungal Drugs Market Size, By Therapeutic Indications: Breakdown(%)
10.7.1 APAC Aspergillosis Antifungal Drugs Market Size, By Value (2013-2023)
10.7.2 APAC Dermatophytosis Antifungal Drugs Market Size, By Value (2013-2023)
10.7.3 APAC Candidiasis Antifungal Drugs Market Size, By Value (2013-2023)
10.7.4 APAC Other Therapeutic Indications Antifungal Drugs Market Size, By Value (2013-2023)

10.8 APAC Antifungal Drugs Market: Country Analysis (China, Japan, and India)
10.8.1 China Antifungal Drugs Market, By Value (2013-2023)
10.8.2 China Antifungal Drugs Market, By Drug Class, By Value (2013-2023)
10.8.3 China Antifungal Drugs Market, By Therapeutic Indications, By Value (2013-2023)

10.8.4 Japan Antifungal Drugs Market, By Value (2013-2023)
10.8.5 Japan Antifungal Drugs Market, By Drug Class, By Value (2013-2023)
10.8.6 Japan Antifungal Drugs Market, By Therapeutic Indications, By Value (2013-2023)

10.8.7 India Antifungal Drugs Market, By Value (2013-2023)
10.8.8 India Antifungal Drugs Market, By Drug Class, By Value (2013-2023)
10.8.9 India Antifungal Drugs Market, By Therapeutic Indications, By Value (2013-2023)

11. ROW Antifungal Drugs Market: Growth and Forecast
11.1 ROW Antifungal Drugs Market: Segmental Analysis
11.2 ROW Antifungal Drugs Market Size, By Drug Class: Breakdown (%)
11.1.1 ROW Antifungal Drugs Market Size, By Drug Class, 2017 (%)
11.1.2 ROW Antifungal Drugs Market Size, By Drug Class, 2023 (%)
11.3 ROW Azole Antifungal Drugs Market Size, By Value (2013-2023)
11.4 ROW Echinocandins Antifungal Drugs Market Size, By Value (2013-2023)
11.5 ROW Polyenes Antifungal Drugs Market Size, By Value (2013-2023)
11.6 ROW Other Antifungal Drugs Market Size, By Value (2013-2023)
11.7 ROW Antifungal Drugs Market Size, By Therapeutic Indications: Breakdown(%)
11.7.1 ROW Aspergillosis Antifungal Drugs Market Size, By Value (2013-2023)
11.7.2 ROW Dermatophytosis Antifungal Drugs Market Size, By Value (2013-2023)
11.7.3 ROW Candidiasis Antifungal Drugs Market Size, By Value (2013-2023)
11.7.4 ROW Other Therapeutic Indications Antifungal Drugs Market Size, By Value (2013-2023)

12. Global Antifungal Drugs Market: Market Dynamics
12.1 Global Antifungal Drugs Market Drivers
12.2 Global Antifungal Drugs Market Restrains
12.3 Global Antifungal Drugs Market Trends

13. Porter Five Force Analysis

14. SWOT Analysis

15. Antifungal Drugs Market – Competitive Landscape

16. Company Profiles
16.1 Merck & Co.
16.2 Pfizer
16.3 GSK
16.4 Novartis
16.5 Abbott Laboratories
16.6 Astellas Pharma
16.7 Bayer
16.8 Sanofi
16.9 Kramer Laboratories
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Merck & Co.
  • Glaxo Smith Kline
  • Astellas Pharma
  • Sanofi
  • Abbott Laboratories
  • Bayer
  • Kramer Laboratories
  • Novartis International AG
  • Pfizer.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4750123
Adroll
adroll